高级检索
当前位置: 首页 > 详情页

Irisin Increased the Number and Improved the Function of Endothelial Progenitor Cells in Diabetes Mellitus Mice.

文献详情

资源类型:
Pubmed体系:
机构: [1]Cell Biological Therapy Center of Kunming General Hospital, Chengdu Military Area Command of PLA, Cell Biological Medicine Integrated Engineering Laboratory of State and Region, Kunming, Yunnan Province, People’s Republic of China [2]Cardiovascular Institute of Xinqiao Hospital, Third Military Medical University, Chongqing, People’s Republic of China [3]Department of Clinical Laboratory, PLA Kunming General Hospital Clinical College of Medicine, Kunming Medical University, Kunming, Yunnan Province, People’s Republic of China
出处:
ISSN:

关键词: endothelial progenitor cells irisin diabetes mellitus proliferation migration endothelial repairing

摘要:
The dysfunction of endothelial progenitor cells (EPCs) was found to be associated with vascular complications in diabetes mellitus (DM) patients. Previous studies found that regular exercise could improve the function of EPCs in DM patients, but the underling mechanism was unclear. Irisin, a newly identified myokine, was induced by exercise and has been demonstrated to mediate some of the positive effects of exercise. In this study, we hypothesize that irisin may have direct effects on EPC function in DM mice. These data showed for the first time that irisin increased the number of EPCs in peripheral blood of DM mice and improved the function of EPCs derived from DM mice bone marrow. The mechanism for the effect of irisin is related to the PI3K/Akt/eNOS pathway. Furthermore, irisin was demonstrated to improve endothelial repair in DM mice that received EPC transplants after carotid artery injury. The results of this study indicate a novel effect of irisin in regulating the number and function of EPCs via the PI3K/Akt/eNOS pathway, suggesting a potential for the administration of exogenous irisin as a succedaneum to improve EPC function in diabetic patients who fail to achieve such improvements through regular exercise.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 3 区 医学
小类 | 3 区 药学 4 区 心脏和心血管系统
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 心脏和心血管系统 4 区 药学
第一作者:
第一作者机构: [1]Cell Biological Therapy Center of Kunming General Hospital, Chengdu Military Area Command of PLA, Cell Biological Medicine Integrated Engineering Laboratory of State and Region, Kunming, Yunnan Province, People’s Republic of China [*1]Cell Biological Therapy Center of Kunming General Hospital, Chengdu Military Area Command of PLA, Cell Biological Medicine Integrated Engineering Laboratory of State and Region, Daguan Road No. 212, Xishan District of Kunming, Kunming 650032, Yunnan Province, People’s Republic of China
共同第一作者:
通讯作者:
通讯机构: [1]Cell Biological Therapy Center of Kunming General Hospital, Chengdu Military Area Command of PLA, Cell Biological Medicine Integrated Engineering Laboratory of State and Region, Kunming, Yunnan Province, People’s Republic of China [*1]Cell Biological Therapy Center of Kunming General Hospital, Chengdu Military Area Command of PLA, Cell Biological Medicine Integrated Engineering Laboratory of State and Region, Daguan Road No. 212, Xishan District of Kunming, Kunming 650032, Yunnan Province, People’s Republic of China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:81956 今日访问量:2 总访问量:678 更新日期:2024-12-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号